Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

Mauricette Michallet, MD, PhD, Quoc Hung Le, MD, Peter Dreger, Mohamad Sobh, PhD, Dietger Niederwieser, MD, Vladimir Koza, MD, Tapani Ruutu, Nigel H. Russell, MD, Leo Verdonck, Donald Milligan, MD, MBChB, Nathalie Dhedin, Tomas Kozak, MD, PhD, Marc Boogaerts, MD, PhD, Juergen Finke, Nathalie Tedone, Anja Van Biezen, Ronald Brand, Theo de Witte on behalfhe European Group for Blood Marrow Transplantation

Blood (2008) 112 (11): 566.

https://doi.org/10.1182/blood.V112.11.566.566

Published: 2008

Journal Articles

Impact of Pre-Transplantation, Mobilization and Graft Variables on Transplant Outcome after Autologus Hematopoietic Stem Cell Transplantation in Multiple Myeloma in Patients

Mauricette Michallet, MD, PhD, Quoc Hung Le, MD, Mohamad Sobh, PhD, Nicole Raus, Melissa Clarck, Jean Vial, Gilles Clapisson, Carole Paillet, Franck E Nicolini, MD, PhD, Jacques Troncy, MD, Xavier Thomas, MD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Vierlizier, MD, Giovanna Cannas, MD, Claudiu Plesa, MD, Fiorenza Baracco, MD

Blood (2008) 112 (11): 5137.

https://doi.org/10.1182/blood.V112.11.5137.5137

Published: 2008

Journal Articles

Long-Term Follow-up of Multiple Myeloma Patients Treated by Bortezomib (Velcade ® ): A Study on Efficacy, Tolerance, Survival and Time to Progression

Mauricette Michallet, MD, PhD, Mohamad Sobh, PhD, Quoc Hung Le, MD, Fiorenza Barraco, MD, Charles Dumontet, MD, PhD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Virelizier, MD, Xavier Thomas, MD, Aline Praire, Claudiu Plesa, MD, Giovanna Cannas, MD, Franck Emmanuel Nicolini, MD, PhD, Jacques Troncy, MD

Blood (2008) 112 (11): 5197.

https://doi.org/10.1182/blood.V112.11.5197.5197

Published: 2008

Journal Articles

Double Cord Blood Cell (CBC) Hematopoietic Stem Cell Transplantation after Standard or Reduced Intensity Conditioning: Report of the SFGMTC Registry.

Blood (2008) 112 (11): 1972.

https://doi.org/10.1182/blood.V112.11.1972.1972

Published: 2008

Journal Articles

Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Patients with High-Risk AML in First CR: The ALFA-0702 Pilot Study.

Xavier Thomas, Ida Lobe, Emmanuel Raffoux, Nicolas Boissel, Quoc-Hung Le, Franck Nicolini, Adrienne de Labarthe, Sandrine Hayette, Jean-Michel Cayuela, Hervé Dombret

Blood (2008) 112 (11): 1934.

https://doi.org/10.1182/blood.V112.11.1934.1934

Published: 2008

Journal Articles

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study

Blood (2008) 112 (11): 765.

https://doi.org/10.1182/blood.V112.11.765.765

Published: 2008

Journal Articles

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne Thiebaut, MD, Sophie Ducastelle, MD, Nicole Raus, Daniela Revesz, MD, Jacques Troncy, MD, Youcef Chelgoum, MD, Jean-Paul Bourgeot, Philippe Dubost, Olivier Hequet, MD PhD, Franck E. Nicolini, MD PhD

Blood (2007) 110 (11): 3048.

https://doi.org/10.1182/blood.V110.11.3048.3048

Published: 2007

Journal Articles

Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Mohamad Mohty, MD, PhD, Franck E. Nicolini, MD, PhD, Jean-Michel Boiron, MD, Hélène Espérou, MD, Michel Attal, MD, PhD, Noel Milpied, MD, Bernard Lioure, MD, Pierre Bordigoni, MD, Ibrahim Yackoub-Agha, MD, PhD, Jean-Henri Bourhis, MD, PhD, Bernard Rio, MD, Eric Deconninck, MD, Marc Renaud, MD, Mohamad Sobh, PhD, Nicole Raus, Didier Blaise, MD

Blood (2007) 110 (11): 1085.

https://doi.org/10.1182/blood.V110.11.1085.1085

Published: 2007

Journal Articles

Multi-Center Prospective Trial on Conditioning with Treosulfan, Fludarabine and ATG Before Allogeneic HSCT from Unrelated Donors.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne Thiebaut, MD, Sophie Ducastelle, MD, Franck E. Nicolini, MD PhD, Nicole Raus, Reza Tabrizi, MD, Krimo Bouabdallah, MD, Didier Blaise, MD PhD, Mohamad Mohty, MD, Catherine Faucher, MD, Sabine Furst, MD, Jacques-Olivier Bay, MD PhD, Eric Hermet, MD, Noel Milpied, MD PhD

Blood (2007) 110 (11): 4949.

https://doi.org/10.1182/blood.V110.11.4949.4949

Published: 2007

Journal Articles

Correlation between MRD and Chimerism Kinetics in CLL Patients after Myeloablative and Non-Myeloablative Allogeneic Hematopoïetic Stem Cell Transplantation.

Adriana Plesa, MD, Quoc-Hung Le, MD, Daniela Revesz, MD, Xavier Thomas, MD PhD, Sophie Ducastelle, MD, Franck E. Nicolini, MD PhD, Anne-Sophie Michallet, MD, Isabelle Mollet, Valerie Dubois, PhD, Melisa Clark, Charles Dumontet, MD PhD, Nicole Raus, Mauricette Michallet, MD PhD

Blood (2007) 110 (11): 5048.

https://doi.org/10.1182/blood.V110.11.5048.5048

Published: 2007

Journal Articles

Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.

Claudiu Plesa, MD, Quoc-Hung Le, MD, Youcef Chelghoum, MD, Mohamed Elhamri, PhD, Isabelle Tigaud, MD, Bruno Anglaret, MD, Sophie Ducastelle, MD, Marie-Claire Perrin, MD, Frank Nicolini, MD, Amine Belhabri, MD, Jacques Troncy, MD, Anne Thiebaut, MD, Daniela Revesz, MD, Eric Wattel, MD, Charles Dumontet, MD, Mauricette Michallet, MD, Xavier Thomas, MD

Blood (2007) 110 (11): 4352.

https://doi.org/10.1182/blood.V110.11.4352.4352

Published: 2007

Journal Articles

Intensive Timed Sequential Chemotherapy Followed by a Single Pegfilgrastim (Neulasta) Administration in Patients with High-Risk Acute Myeloid Leukemia (AML): Preliminary Results of the EMA-2000/Neu Trial.

Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Anne Thiebaut, MD, Mohamed Elhamri, PhD, Emmanuelle Tavernier, MD, Nabaz Jaff, MD, Quoc-Hung Le, MD, Mauricette Michallet, MD,PhD

Blood (2006) 108 (11): 4558.

https://doi.org/10.1182/blood.V108.11.4558.4558

Published: 2006

Journal Articles

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Thomas Prebet, MD, Quoc-Hung Le, MD, Jean-Michel Boiron, MD, Didier Blaise, MD, Anne Huynh, MD, Ibrahim Yakoub-Agha, MD, Hélène Esperou, MD, Fréderic Garban, MD, PhD, Jean Henri Bourhis, MD, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 1146.

https://doi.org/10.1182/blood.V106.11.1146.1146

Published: 2005

Journal Articles

Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).

Sophie Ducastelle, MD, Daniela Revesz, MD, Jacques Troncy, MD, Samira Mahmoudi, MD, Xavier Thomas, MD, PhD, Anne Thiebaut, MD, Franck E. Nicolini, MD, PhD, Emmanuelle Tavernier, MD, Quoc-Hung Le, MD, Youssef Chelgoum, MD, Aline Praire, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 5399.

https://doi.org/10.1182/blood.V106.11.5399.5399

Published: 2005

Journal Articles

Transplant Outcome of Unrelated Hematopoietic Stem Cell Transplantation (HSCT) after Myelo-Ablative or Reduced Intensity Conditioning (RIC) for Chronic Lymphocytic Leukemia(CLL). A Study of EBMT Registry.

Mauricette Michallet, MD, PhD, Thomas Prebet, MD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Anja Van Biezen, Ronald Brand, PhD, Peter Dreger, MD, Dietger W. Niederwieser, MD, PhD

Blood (2005) 106 (11): 561.

https://doi.org/10.1182/blood.V106.11.561.561

Published: 2005

Journal Articles

Effect of Priming with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Younger Adults with Newly Diagnosed Acute Myeloid Leukemia (AML): A Trial by the Acute Leukemia French Association (ALFA) Group.

Blood (2005) 106 (11): 1862.

https://doi.org/10.1182/blood.V106.11.1862.1862

Published: 2005

Journal Articles

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Thomas Prebet, MD, Mohamad Mohty, MD, PhD, Jean Michel Boiron, MD, Hélène Esperou, MD, Noel Milpied, MD, Nathalie Dhédin, MD, Didier Blaise, MD

Blood (2005) 106 (11): 45.

https://doi.org/10.1182/blood.V106.11.45.45

Published: 2005

Journal Articles

Gemtuzumab Ozogamicin (Mylotarg ® ) as Single Agent Treatment for Adult Patients with Acute Myeloid Leukemia (AML).

Xavier Thomas, Quoc-Hung Le, Emmanuelle Tavernier, Samira Mahmoudi, Youcef Chelghoum, Franck Nicolini, Anne Thiebaut, Jacques Troncy, Daniela Revesz, Mohamed Elhamri, Mauricette Michallet

Blood (2005) 106 (11): 4598.

https://doi.org/10.1182/blood.V106.11.4598.4598

Published: 2005

Journal Articles

Impact of Peripheral Blood Stem Cell Recruitment on Outcome of Single or Double Autologous Hematopoietic stem Cell Transplantation for Multiple Myeloma.

Mauricette Michallet, MD PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Anne Thiebaut, MD, Emmanuelle Tavernier, MD, Jacques Troncy, MD, Xavier Thomas, MD PhD, Youcef Chelghoum, MD, Aline Praire, Elodie Gadolet, Franck E. Nicolini, MD PhD, Gilles Clapisson, Irene Philip, MD

Blood (2004) 104 (11): 5221.

https://doi.org/10.1182/blood.V104.11.5221.5221

Published: 2004

Journal Articles

Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Anne Thiebaut, MD, Emannuelle Tavernier, MD, Hanadi Rafii, MD, Daniela Revesz, MD, Jacques Troncy, MD, Aline Praire, Elodie Gadolet, Valerie Dubois, PhD, Lucette Gebuhrer, MD, Olivier Hequet, MD, PhD, Jean-Paul Bourgeot, Franck E. Nicolini, MD, PhD

Blood (2004) 104 (11): 2305.

https://doi.org/10.1182/blood.V104.11.2305.2305

Published: 2004

NARROW

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

Impact of Pre-Transplantation, Mobilization and Graft Variables on Transplant Outcome after Autologus Hematopoietic Stem Cell Transplantation in Multiple Myeloma in Patients

Long-Term Follow-up of Multiple Myeloma Patients Treated by Bortezomib (Velcade ® ): A Study on Efficacy, Tolerance, Survival and Time to Progression

Double Cord Blood Cell (CBC) Hematopoietic Stem Cell Transplantation after Standard or Reduced Intensity Conditioning: Report of the SFGMTC Registry.

Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Patients with High-Risk AML in First CR: The ALFA-0702 Pilot Study.

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Multi-Center Prospective Trial on Conditioning with Treosulfan, Fludarabine and ATG Before Allogeneic HSCT from Unrelated Donors.

Correlation between MRD and Chimerism Kinetics in CLL Patients after Myeloablative and Non-Myeloablative Allogeneic Hematopoïetic Stem Cell Transplantation.

Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.

Intensive Timed Sequential Chemotherapy Followed by a Single Pegfilgrastim (Neulasta) Administration in Patients with High-Risk Acute Myeloid Leukemia (AML): Preliminary Results of the EMA-2000/Neu Trial.

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).

Transplant Outcome of Unrelated Hematopoietic Stem Cell Transplantation (HSCT) after Myelo-Ablative or Reduced Intensity Conditioning (RIC) for Chronic Lymphocytic Leukemia(CLL). A Study of EBMT Registry.

Effect of Priming with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Younger Adults with Newly Diagnosed Acute Myeloid Leukemia (AML): A Trial by the Acute Leukemia French Association (ALFA) Group.

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Gemtuzumab Ozogamicin (Mylotarg ® ) as Single Agent Treatment for Adult Patients with Acute Myeloid Leukemia (AML).

Impact of Peripheral Blood Stem Cell Recruitment on Outcome of Single or Double Autologous Hematopoietic stem Cell Transplantation for Multiple Myeloma.

Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only